Clinical-stage company developing gene therapies for severe genetic and rare diseases.
S. 2543 Prescription Drug Pricing Act and issues related to value based payment over time; H.R. 5882 Gene Therapy Payment Act; H.R. 3935, the Protecting Patients Transportation to Care Act; issues related to the Notice of Proposed rulemaking supporting VBP Arrangement; issues related to the Executive Order on Lowering Drug Prices by Putting America First.
MMM - Medicare/Medicaid
34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
EMILY PORTER STACEY HUGHES